CLINICAL TRIALS PROFILE FOR DWP16001
✉ Email this page to a colleague
Clinical Trials for DWP16001
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT03364985 ↗ | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 1 | This is a dose block-randomized, double-blind, placebo- and active-controlled, single and multiple dosing, dose-escalation clinical phase 1 trial to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of DWP16001 after oral administration in healthy male volunteers. |
| NCT04014023 ↗ | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus | Unknown status | Daewoong Pharmaceutical Co. LTD. | Phase 2 | The purpose of this study is to determine the efficacy and safety of DWP16001 compared to placebo in the treatment of type 2 diabetes mellitus. |
| NCT04064073 ↗ | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study) | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 1 | The purpose of this study is to evaluate drug-drug interaction of DWP16001 in combination with metformin IR 1000mg in Healthy male subjects. |
| NCT04221399 ↗ | Type 2 Diabetes Patients With Renal Impairment | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | Phase 1 | The purpose of the study is to evaluate the effect of kidney function on pharmacokinetics and pharmacodynamics of DWP16001 following single and multiple oral doses in type 2 diabetes patients with normal kidney function and renal impairment. |
| NCT04343547 ↗ | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | Phase 1 | The purpose of this study is to evaluate drug-drug interaction by comparing the pharmacokinetics (PK)/pharmacodynamics (PD), safety, and tolerability of single/multiple doses of DWP16001 , DWC202001 and DWC202002 alone or in combination in healthy male adults. |
| NCT04632862 ↗ | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. | Enrolling by invitation | Daewoong Pharmaceutical Co. LTD. | Phase 3 | The purpose of this study is to determine the efficacy and safety of DWP16001 compared to placebo in the treatment of type 2 diabetes mellitus. |
| NCT04634500 ↗ | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | Recruiting | Daewoong Pharmaceutical Co. LTD. | Phase 3 | Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of DWP16001 in Combination with Metformin in Patients With Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on Metformin Alone. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for DWP16001
Condition Name
Clinical Trial Locations for DWP16001
Clinical Trial Progress for DWP16001
Clinical Trial Phase
Clinical Trial Sponsors for DWP16001
Sponsor Name
